Diabetic Retinopathy clinical trials at UCSD
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
To show the non-inferiority of EGRIFTA® vs. placebo in the development or progression of Diabetic Retinopathy in HIV-infected subjects with concomitant abdominal lipohypertrophy and Type 2 diabetes mellitus (T2DM).
San Diego, California and other locations